-
Los Angeles Map Shows 2028 Olympics Venue Locations - 13 mins ago
-
Tour of Jasper wildfire devastation reveals destroyed homes and hotels - 17 mins ago
-
Bodrum: The Turkish holiday resort has gone from cheap to A-lister hangout - 18 mins ago
-
Xiaomi Mix Flip Price, Launch Date in Global Markets Reportedly Confirmed by Company Executive - 19 mins ago
-
Olympics 2024: Indian Shooters Fail To Make Medal Matches In Mixed Team - 21 mins ago
-
“Britain is open for business” — MercoPress - 24 mins ago
-
Northamptonshire officers on poignant ride for fallen colleague - 25 mins ago
-
Will Men Vote for Kamala Harris? Polls Paint Bleak Picture for Democrats - 33 mins ago
-
Jordan Love, Packers reportedly agree to 4-year, $220 million extension - 36 mins ago
-
Ipswich chef says making 3,000 toasties at Latitude is dream job - 39 mins ago
Shares of Novartis climb 4.8% on raised guidance, better-than-expected results
Signage for Novartis AG at a building in the company’s headquarters campus in Basel, Switzerland, on Monday, Jan. 8, 2023.
Bloomberg | Bloomberg | Getty Images
Shares of Swiss drugmaker Novartis climbed 4.8% in early deals on Tuesday, after the company raised its full-year guidance following better-than-expected first-quarter results.
The company said 2024 net sales are now anticipated to pick up by a high-single to low double-digit percentage, up from a previous outlook of mid-single-digit growth.
The drugmaker has also revised its expectations for core operating income, now set to expand by a low double-digit to mid-teens percentage, up from the high single-digit growth forecast prior.
This breaking news story is being updated.
Source link